89bio (NASDAQ:ETNB – Get Rating) had its price target upped by Bank of America from $17.00 to $24.00 in a research note issued to investors on Sunday morning, The Fly reports. Several other equities analysts also recently commented on the company. Cantor Fitzgerald upped their target price on 89bio from $34.00 to $45.00 in a […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) CEO Rohan Palekar sold 15,000 shares of 89bio stock in a transaction dated Thursday, March 23rd. The shares were sold at an average price of $16.00, for a total value of $240,000.00. Following the completion of the sale, the chief executive officer now owns 269,080 shares of the company’s […]
89bio (NASDAQ:ETNB – Get Rating) had its price objective hoisted by Bank of America from $17.00 to $24.00 in a research report released on Sunday morning, The Fly reports. Several other equities analysts have also weighed in on ETNB. Oppenheimer raised their price objective on shares of 89bio from $18.00 to $33.00 in a research […]
89bio (NASDAQ:ETNB – Get Rating) had its target price hoisted by Bank of America from $17.00 to $24.00 in a research report released on Sunday morning, The Fly reports. ETNB has been the topic of several other reports. Oppenheimer upped their price target on 89bio from $18.00 to $33.00 in a research report on Wednesday, […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) CFO Ryan Martins sold 5,000 shares of the firm’s stock in a transaction dated Thursday, March 23rd. The stock was sold at an average price of $16.11, for a total value of $80,550.00. Following the completion of the sale, the chief financial officer now directly owns 53,578 shares in […]